You are here: Home » 
  1. News

| First COVID-19 Registry in Rhineland-Palatinate, Germany

Supported by the Ministry of Social Affairs, Labour, Health and Demography of Rhineland-Palatinate, IHF GmbH manages the COVID-19-Registry Rhineland-Palatinate, which was launched this weekend. Registry for Rhineland-Palatinate for the documentation of all patients who are in hospital treatment for SARS-CoV-2 infection with regard to their clinical status at admission, Pre-existing conditions, inpatient therapies and course of disease.

The COVID-19 Registry is a multicentre, non-interventional, prospective observational study implemented in Germany, currently in Rhineland-Palatinate. The study is managed by IHF GmbH - Institut für Herzinfarktforschung, Ludwigshafen and supported by the Ministry of Social Affairs, Labour, Health and Demography Rhineland-Palatinate. Aim of the registry is to characterise inpatients with SARS-CoV-2 infection in Rhineland-Palatinate, to describe the therapeutic strategies and to develop a risk stratification for severe disease progression. Under the scientific management of Dr. Anselm Gitt (Senior cardiologist of the Ludwigshafen Hospital and Deputy Chairman of the IHF), data of patients with a SARS-CoV-2 infection undergoing inpatient treatment will be evaluated. The aim is to establish a risk stratification of the infection based on clinical parameters as well as therapy and disease progression of the patients. This may also contribute to better resource planning. The primary objective is to determine the clinical status at admission, pre-existing conditions, therapeutic strategies and the clinical course of the infection. The study is a prospective observational study and the inclusion in the register is completely independent of the medical treatment. In the current planning, the register study is planned as a cross-sectional study of all SARS-CoV-2-infected patients. Subject to further development, a longitudinal study of the affected patients may be incorporated in order to assess the long-term course after inpatient treatment. This could provide valuable scientific and therapeutically significant data on the long-term development of COVID-19 patients. Patients will be informed about this option in advance and can decide separately whether to participate in the long-term observation. For patients, participation is entirely voluntary based on transparent information and informed consent.

COVID-19 Registry in Rhineland-Palatinate

News

We would like to get to know you and your ideas.

Start project

Consent to the use of cookies

In order to make our website more appealing to visitors and to enable the use of certain functions, we use cookies on various pages. By continuing to use the website, you consent to the use of cookies. Find out more.

I agree
Scroll to top